What nomenclature is used in naming the biologics?
- • cept: receptor drug which prevents a ligand from binding to its receptor (e.g., ETN, abatacept, rilonacept).
- • ximab: chimeric monoclonal antibody (e.g., INF, RTX).
- • zumab: humanized monoclonal antibody (e.g., certolizumab, tocilizumab, ixekizumab, eculizumab).
- • umab: fully human monoclonal antibody (e.g., ADA, golimumab, belimumab, ustekinumab).
- • ra: receptor antagonist (e.g., anakinra).
